Vandetanib-d4 化学特性,用途語,生産方法
使用
A labelled Vandetanib; a once-daily oral inhibitor of vascular endothelial growth factor receptor-2 and epidermal growth factor receptor kinase activity. The activity of vandetanib plus docetaxel was
assessed in patients with previously treated non-small-cell lung cancer (NSCLC).
Vandetanib-d4 上流と下流の製品情報
原材料
準備製品